Quantcast

Latest Health Medical Pharma Stories

2014-07-30 16:29:49

DUBLIN, July 30, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) today announced the appointment of Shane M. Cooke to the company's board of directors. Mr. Cooke, an international business leader with more than 25 years of experience, currently serves as president of Alkermes plc based in Dublin, Ireland. Mr. Cooke has also been appointed to Endo's Audit and Transactions Committee. "I am excited to welcome Shane to our board of directors," said Roger Kimmel,...

2014-07-30 16:29:33

LEXINGTON, Mass., July 30, 2014 /PRNewswire/ -- Synageva BioPharma Corp. ("Synageva") (NASDAQ: GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today reported second quarter 2014 financial results, and provided other business updates. Second Quarter 2014 Financial Results For the quarter ended June 30, 2014, Synageva reported a net loss of $50.2 million compared to a net loss of $22.1 million for the corresponding quarter of the prior year....

2014-07-30 16:29:31

No Customer or Revenue Impact Expected SUNNYVALE, Calif., July 30, 2014 /PRNewswire/ -- Cepheid (Nasdaq: CPHD) today announced that its group purchasing contract with Premier will end on September 30, 2014. Customers currently purchasing through the Premier GPO will be able to continue their relationship with Cepheid through other GPOs including Amerinet, Baycare, HPA, MedAssets, Novation, and ROi, in addition to the recently announced agreement with HealthTrust, or directly with...

2014-07-30 16:29:26

LA JOLLA, Calif., July 30, 2014 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights for the quarter ended June 30, 2014 on Wednesday, August 6, 2014, after the U.S. financial markets close. Regulus will host a conference call and webcast on Wednesday, August 6, 2014, at 5:00 pm Eastern Daylight Time...

2014-07-30 16:29:22

TARRYTOWN, N.Y. and PARIS, July 30, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that the Companies intend to use a U.S. Food and Drug Administration (FDA) rare pediatric disease priority review voucher in connection with the Biologics License Application (BLA) submission for alirocumab. The priority review voucher entitles the holder to designate a BLA for priority review, which provides for an expedited...

2014-07-30 16:29:14

BEDFORD, Mass., July 30, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced its results for the third fiscal quarter ended June 28, 2014. Third Quarter Financial Highlights and Recent Developments: -- Revenues increased 1.0% to $632.6 million, reflecting operational growth of 0.5% and a positive currency impact of 0.5%, compared to the same period in the prior year. -- Revenues grew in three of the four business segments. -- Breast Health...

2014-07-30 16:29:12

AMCP was one of ten national pharmacy groups that developed document ALEXANDRIA, Va., July 30, 2014 /PRNewswire-USNewswire/ -- The Board of Directors of the Academy of Managed Care Pharmacy (AMCP) last evening expressed support for the "Pharmacists' Patient Care Process" recently developed by the Joint Commission of Pharmacy Practitioners (JCPP). As a JCPP member, AMCP worked with other member organizations over a two-year period to develop a scalable, viable and consistent patient...

2014-07-30 16:29:10

For Accelerated Approval of Therapies for Duchenne Muscular Dystrophy WASHINGTON, July 30, 2014 /PRNewswire/ -- In response to the 106,782 signatures collected through TheRacetoYes.Org petition urging the "FDA to Say Yes to Accelerated Approval for safe, effective therapies for children with Duchenne" muscular dystrophy, the White House issued a statement yesterday by Janet Woodcock, Director, FDA Center for Drug Evaluation and Research. The Race to Yes organizers expressed...

2014-07-30 16:29:08

SAN MARCOS, Calif., July 30, 2014 /PRNewswire/ --Natural Alternatives International, Inc. ("NAI") (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that it has settled its unfair competition and patent infringement claims against DNP International Co., Inc. in U.S. District Court for the District of Delaware. As a result of the settlement, DNP will immediately end its involvement in business related to beta-alanine,...

2014-07-30 16:29:05

FORT LAUDERDALE, Fla., July 30, 2014 /PRNewswire/ -- Integrative Stem Cell Holdings, Inc., a corporation formerly known as YaFarm Technologies, Inc. (OTC: YFRM) (OTC Pink: YFRM), announced today that it has filed an Amended and Restated Certificate of Incorporation with the Secretary of State of Delaware which changes the company's name to "Profile Solutions, Inc." and effects a 1:10 reverse stock split of its outstanding common stock, among other actions. The effective date of the...


Latest Health Medical Pharma Reference Libraries

British Friesian Cattle
2014-07-12 11:44:10

The British Friesian is a breed of cattle from the United Kingdom. The modern British Friesian dominated the dairy cattle population from the 1950s through the 1980s. Stock as well as semen were exported during this time throughout the world. The original Friesian breed was imported to ports of England and Scotland during the 1800s until it was stopped in 1892 when a threat of foot and mouth disease became a concern. By the end of 1912 there were 1,000 bulls and 6,000 cows registered in...

Blue Gray Cattle
2014-07-12 10:27:38

The Blue Grey is a breed of beef cattle that is popular in Scotland and north of England. It was developed by crossing a white bred shorthorn and Black Galloway cows. The color of the Blue Grey is roan blue. However, roan coloration is not a dominant color gene and the color does not always hold true. Only about half of the calves born to two true blue roan cattle will be blue roan, the rest will be either solid white or solid black. Blue roan is only consistent in the first generation of...

Belgian Blue Cattle
2014-07-09 14:37:46

The Belgian Blue is a breed of beef cattle originating in Belgium. It was developed in the 1800s by crossbreeding local cattle with a Shorthorn breed from the United Kingdom. It is quite possible that the Charolais cattle was also used in the development of the Belgian Blue. A modern breed of the Belgian blue was developed in the 1950s by Professor Hanset while working at an artificial insemination facility in the Liege province. The breed was introduced to the United States in 1978 by...

Obesophobia
2013-12-24 13:50:12

Obesophobia or Pocrescophobia, from the Greek phobia, meaning fear or morbid fear and obeso, meaning fat, is a persistent and abnormal fear of gaining weight, especially in cultures that value being thin. This phobia was listed as a rare disease by the Office of Rare Diseases of the National Institutes of Health. Certain individuals suffering from this phobia originally start with a desire to lose weight which turns into a compulsive desire to avoid all of the things that could result in...

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

More Articles (393 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related